Avid Bioservices Reports Financial Results for Fourth Quarter and Fiscal Year Ended April 30, 2024

-- Signed $30 Million in Net New Business Resulting in Backlog of $193 Million -- -- FY 2025 Revenue Guidance of Between $160 Million and $168 Million -- "The fourth quarter of fiscal 2024 was a high point for the company," stated Nick Green, president and CEO of Avid Bioservices. "We generated the highest quarterly revenues in Avid's history, meeting our current revenue expectations for the year. During the period we signed multiple new project agreements, and we continue to see positive signs for business ...